Other substances

Palbociclib

A cyclin dependent kinase inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Other treatment

Drug status

Used to treat other disease

3
 Supporting references
0
 Contradictory references
1
 AI-suggested references
0
 Clinical trials

General information

Palbociclib on PubChem

Marketed as

IBRANCE

 

Structure image - Palbociclib

CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C

Supporting references

Link Tested on Impact factor Notes Publication date
The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States
Preprint 		in silico

one of the top drugs and compounds identified by ViroTreat

 May/17/2020
A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
RdRpol Small molecule In silico 		adenocarcinomic human alveolar basal epithelial cells 3.22

Predicted to bind the SARS-CoV-2 RNA-dependent RNA polymerase.

 Sep/18/2020
Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19
Small molecule In silico 		in silico 8.99

Computational modelling predicts that the drug interacts with SARS-CoV-2 infection-related signalling pathways.

 Apr/12/2021

AI-suggested references

Link Publication date
Community Birth: The Value of Collaboration.
Oct/29/2020
Export (.csv)